ArticleFrontiers in pediatrics2026
A recurrence prediction model based on serological indicators in children with acute pancreatitis without pancreaticobiliary anatomical abnormalities.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore the related influencing factors of recurrent acute pancreatitis in children and provide a reference for clinical early identification of high-risk children with recurrent acute pancreatitis (RAP). Methods: A retrospective case-control study was designed to collect the clinical data of 101 children who were diagnosed with acute pancreatitis (AP) and hospitalized in Anhui Children's Hospital from July 2020 to December 2025. The children were divided into two groups according to the recurrence of the disease: the acute pancreatitis group (only one hospitalization due to AP during the study period, Results: Univariate analysis showed that there were statistically significant differences in triglyceride (TG), high density lipoprotein (HDL), blood glucose (BG) and D-dimer levels between the two groups ( Conclusion: HDL is an independent protective factor for RAP in children, while BG and D-dimer are independent risk factors. Clinical combined detection of these three indicators can improve the accuracy of early diagnosis of RAP and provide a basis for precise intervention in high-risk children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.